Problem statement: Answer the multiple-choice question.
Question: Which drug has a -23.455% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) O=C(NCCO)/C(=C\c1ccco1)NC(=O)c1ccco1
b.) CSc1ncccc1C(=O)Nc1nc(C(C)(C)C)cs1
c.) COc1ccc(CCNC(=O)CN2CCC(C)CC2)cc1OC.O=C(O)C(=O)O
d.) CN(C)c1ccc(NC(=O)CN2C(=O)c3ccccc3C2=O)cc1
Answer: b. CSc1ncccc1C(=O)Nc1nc(C(C)(C)C)cs1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSc1ncccc1C(=O)Nc1nc(C(C)(C)C)cs1
CSc1ncccc1C(=O)Nc1nc(C(C)(C)C)cs1
N-(4-tert-butyl-1,3-thiazol-2-yl)-2-methylsulfanylpyridine-3-carboxamide